BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28229160)

  • 1. Pregnancy outcome of first trimester exposure to the vitamin K antagonist phenprocoumon depends on duration of treatment.
    Hüttel E; Padberg S; Meister R; Beck E; Schaefer C
    Thromb Haemost; 2017 May; 117(5):870-879. PubMed ID: 28229160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
    Schaefer C; Hannemann D; Meister R; Eléfant E; Paulus W; Vial T; Reuvers M; Robert-Gnansia E; Arnon J; De Santis M; Clementi M; Rodriguez-Pinilla E; Dolivo A; Merlob P
    Thromb Haemost; 2006 Jun; 95(6):949-57. PubMed ID: 16732373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.
    Weber-Schoendorfer C; Oppermann M; Wacker E; Bernard N; ; Beghin D; Cuppers-Maarschalkerweerd B; Richardson JL; Rothuizen LE; Pistelli A; Malm H; Eleftheriou G; Kennedy D; Kadioglu Duman M; Meister R; Schaefer C
    Br J Clin Pharmacol; 2015 Oct; 80(4):727-39. PubMed ID: 25808588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort study.
    Hoeltzenbein M; Fietz AK; Kayser A; Zinke S; Meister R; Weber-Schoendorfer C; Schaefer C
    J Hypertens; 2018 Oct; 36(10):2109-2117. PubMed ID: 29985206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study.
    Dathe K; Padberg S; Hultzsch S; Köhler LM; Meixner K; Fietz AK; Tissen-Diabaté T; Meister R; Schaefer C
    Eur J Clin Pharmacol; 2018 Apr; 74(4):489-495. PubMed ID: 29214381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes.
    Bérard A; Zhao JP; Shui I; Colilla S
    Ann Rheum Dis; 2018 Apr; 77(4):500-509. PubMed ID: 29222350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multistate methodology improves risk assessment under time-varying drug intake-a new view on pregnancy outcomes following coumarin exposure.
    Bluhmki T; Fietz AK; Stegherr R; Beck E; Padberg S; Beyersmann J; Schaefer C; Meister R
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):616-624. PubMed ID: 30828912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study.
    Hoeltzenbein M; Tissen-Diabaté T; Fietz AK; Zinke S; Kayser A; Meister R; Weber-Schoendorfer C; Schaefer C
    Clin Res Cardiol; 2018 Aug; 107(8):679-687. PubMed ID: 29574489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones.
    Padberg S; Wacker E; Meister R; Panse M; Weber-Schoendorfer C; Oppermann M; Schaefer C
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4392-8. PubMed ID: 24841264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives.
    Gärtner BC; Seifert CB; Michalk DV; Roth B
    Z Geburtshilfe Perinatol; 1993; 197(6):262-5. PubMed ID: 8147045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort study.
    Hoeltzenbein M; Tissen-Diabaté T; Fietz AK; Zinke S; Kayser A; Meister R; Weber-Schoendorfer C; Schaefer C
    Pregnancy Hypertens; 2018 Jul; 13():65-71. PubMed ID: 30177074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ondansetron in pregnancy and risk of adverse fetal outcomes.
    Pasternak B; Svanström H; Hviid A
    N Engl J Med; 2013 Feb; 368(9):814-23. PubMed ID: 23445092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study.
    Habermann F; Fritzsche J; Fuhlbrück F; Wacker E; Allignol A; Weber-Schoendorfer C; Meister R; Schaefer C
    J Clin Psychopharmacol; 2013 Aug; 33(4):453-62. PubMed ID: 23764684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coumarin embryopathy after intrauterine exposure to vitamin K antagonists within the first 10 postmenstrual weeks.
    Hoyer AC; Henrich W; Schaefer C; Spors B; Czernik C
    Ultraschall Med; 2010 Aug; 31(4):411-3. PubMed ID: 20703972
    [No Abstract]   [Full Text] [Related]  

  • 16. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome.
    Wacker E; Navarro A; Meister R; Padberg S; Weber-Schoendorfer C; Schaefer C
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):353-60. PubMed ID: 25644395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Trimester Anticoagulant Exposure and Adverse Pregnancy Outcomes in Women with Preconception Venous Thromboembolism: A Nationwide Cohort Study.
    Søgaard M; Skjøth F; Nielsen PB; Beyer-Westendorf J; Larsen TB
    Am J Med; 2022 Apr; 135(4):493-502.e5. PubMed ID: 34798098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
    Weber-Schoendorfer C; Chambers C; Wacker E; Beghin D; Bernard N; ; Shechtman S; Johnson D; Cuppers-Maarschalkerweerd B; Pistelli A; Clementi M; Winterfeld U; Eleftheriou G; Pupco A; Kao K; Malm H; Elefant E; Koren G; Vial T; Ornoy A; Meister R; Schaefer C
    Arthritis Rheumatol; 2014 May; 66(5):1101-10. PubMed ID: 24470106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.
    Chambers CD; Johnson D; Xu R; Luo Y; Louik C; Mitchell AA; Schatz M; Jones KL;
    Vaccine; 2013 Oct; 31(44):5026-32. PubMed ID: 24016809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of cetirizine during pregnancy. A prospective observational cohort study.
    Weber-Schoendorfer C; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.